3691 - 3700 of 6255 Results
Title
Year
- Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease2018OPENTitle: Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0255-7Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0255-7Citation Count: 52
- Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors2015OPENTitle: Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitorsJournal Name: Molecular and Cellular NeurosciencePublisher: Elsevier BVVol: 68Issue #:Start Page: 131End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.mcn.2015.07.002Best OA location URL: http://doi.org/10.1016/j.mcn.2015.07.002Citation Count: 32
-
OPENTitle: The importance of a healthy mouth in Parkinson's diseaseJournal Name: The LancetPublisher: Elsevier BVVol: 402Issue #: 10411Start Page: 1419End Page: 1420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(23)01466-6Best OA location URL: http://www.thelancet.com/article/S0140673623014666/pdfCitation Count: 5
- Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers2023OPENTitle: Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00445-9Best OA location URL: https://www.nature.com/articles/s41531-023-00445-9.pdfCitation Count: 17
- The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain2019OPENTitle: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrainJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 323Issue #:Start Page: 113062End Page: 113062Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062Best OA location URL: https://opus.lib.uts.edu.au/bitstream/10453/136564/4/Binder1.pdfCitation Count: 14
- Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?2013OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 50
- Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils2023OPENTitle: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau ProtofibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 18Start Page: 3528End Page: 3539Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437Best OA location URL: https://doi.org/10.1021/acschemneuro.3c00437Citation Count: 16
-
OPENTitle: Aging, Parkinson’s Disease, and Models: What Are the Challenges?Journal Name: Aging BiologyPublisher: Aging Biology LLCVol: 1Issue #: 1Start Page: 20230010End Page: 20230010Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.59368/agingbio.20230010Best OA location URL: https://agingcelljournal.org/Archive/Volume3/ageing_parkinsons_disease_and_models/agingbio.20230010.pdfCitation Count: 4
- Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease2023OPENTitle: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43856-023-00294-wBest OA location URL: https://www.nature.com/articles/s43856-023-00294-w.pdfCitation Count: 30
-
OPENTitle: PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity terminationJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 217Issue #: 6Start Page: 2167End Page: 2184Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.201708053Best OA location URL: https://rupress.org/jcb/article-pdf/217/6/2167/1067112/jcb_201708053.pdfCitation Count: 49